Paragon Offshore plc (NYSE:PGN) announced that it plans to report financial results for the fourth quarter and full year 2014 on Thursday, February 19, 2015, after the close of trading on the New York Stock Exchange. On Tuesday shares of Paragon Offshore plc (NYSE:PGN) closed at $3.13.
TechTarget, Inc. (NASDAQ:TTGT) announced that it plans to release its 2014 fourth quarter and full year financial results after the market closes on Wednesday, February 11, 2015. The Company’s management team will host a live conference call and webcast at 5:00 p.m. Eastern Time on that day to discuss the Company’s financial results. TechTarget, Inc. (NASDAQ:TTGT) in last trading activity increased 1.61% to close at $11.37. Company weekly performance is 1.43% while its quarterly performance stands at 11.47%. TechTarget, Inc. (NASDAQ:TTGT) is -3.97% away from its 52 week high.
Ericsson (NASDAQ:ERIC) was downgraded by equities research analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research note issued to investors on Wednesday. Ericsson (NASDAQ:ERIC) has institutional ownership stands at 5.50%. In last trading activity company’s stock closed at $12.52.
Compugen Ltd. (NASDAQ:CGEN) reported a loss of $1.5 million in its fourth quarter. For the year, the company reported that its loss narrowed to $11.1 million, or 23 cents per share. Revenue was reported as $12.4 million. Compugen Ltd. (NASDAQ:CGEN) has 10.04% insider ownership while its institutional ownership stands at 18.20%. In last trading activity company’s stock closed at $8.32.
On 1 February, Pharmacyclics Inc. (NASDAQ:PCYC) announced that the US Food and Drug Administration (FDA) has approved its drug Imbruvica (ibrutinib) for all lines of therapy for treating patients with Waldenstrom’s macroglobulinemia (WM), a type of non-Hodgkin lymphoma. On last trading day Pharmacyclics Inc. (NASDAQ:PCYC) increased 1.29% to close at $164.50. Its volatility for the week is 4.12% while volatility for the month is 4.24%. PCYC’s EPS growth for past 5 years was 24.50%. Pharmacyclics Inc. (NASDAQ:PCYC) monthly performance is 32.45%.